• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Precigen, Inc. - Common Stock (NQ:PGEN)

    4.141 -0.279 (-6.31%)
    Streaming Delayed Price Updated: 1:56 PM EDT, May 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Precigen, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    Recap: Precigen Q1 Earnings ↗
     
    Via Benzinga
    News headline image
    7 High-Potential Penny Stocks in the Biotech Sector ↗
    Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. 
    Via InvestorPlace
    News headline image
    3 High-Growth Biotech Stocks Poised for Success in 2023 ↗
    If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity 
    Via InvestorPlace
    News headline image
    3 Healthcare Stocks Insiders Are Buying
    The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too. 
    Via MarketBeat
    News headline image
    Precigen Regains Rights To CAR-T Platform For Hematological, Solid Tumor Indications ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Precigen's Return On Capital Employed Insights ↗
     
    Via Benzinga
    News headline image
    Earnings Preview For Precigen ↗
     
    Via Benzinga
    News headline image
    2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years ↗
    Biotechs are capable of making huge gains in short periods, and they often do. 
    Via The Motley Fool
    News headline image
    Founders at These 7 Companies Are Loading Up on Their Stock. Should You? ↗
    Insiders sell for all kinds of reasons. There’s only one reason for insider buying. These seven founders and CEOs are loading up. 
    Via InvestorPlace
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
    We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! 
    Via InvestorPlace
    News headline image
    3 Penny Stocks The Insiders Are Buying
    The insiders are buying these penny stocks with support from analysts and institutions. Could they be the next big winners? 
    Via MarketBeat
    Topics Intellectual Property
    News headline image
    Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week ↗
    Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week. 
    Via The Motley Fool
    News headline image
    Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response ↗
    New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to... 
    Via Benzinga
    News headline image
    Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response
    Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response 
    Via News Direct
    News headline image
    $20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying ↗
    The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
    Via Benzinga
    News headline image
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About ↗
    Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this... 
    Via Benzinga
    News headline image
    Nasdaq Falls 50 Points; eHealth Shares Spike Higher ↗
    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18.... 
    Via Benzinga
    News headline image
    Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. 
    Via Benzinga
    News headline image
    Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings ↗
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96.... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    US Stocks Open Lower; Dow Dips 250 Points ↗
    U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗
    Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a... 
    Via Benzinga
    News headline image
    3 Penny Stocks That Could Make You Filthy Rich ↗
    These low-priced equities could deliver enormous returns for risk-tolerant shareholders. 
    Via The Motley Fool
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    It's time to start off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday! 
    Via InvestorPlace
    News headline image
    Intuitive Surgical, Microsoft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
    By Faith Ashmore, Benzinga 
    Via News Direct
    Topics Death
    Precigen’s Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
    Acute myeloid leukemia (AML) is among the most common types of leukemia in adults. The term leukemia refers to cancers of the bone marrow and blood cells. Doctors refer to AML as “acute” because the... 
    Via TheNewswire.com
    Topics Death
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.